David M Tanen's Net Worth
$20.4 Million
Who is David M Tanen?
David M Tanen has an estimated net worth of $20.4 Million. This is based on reported shares across multiple companies, which include Kronos Bio, Inc., MANHATTAN PHARMACEUTICALS INC, Nile Therapeutics, Inc., Arno Therapeutics, Inc, Cougar Biotechnology, Inc., IVORY CAPITAL CORP, and CHIRAL QUEST INC.
SEC CIK
David M Tanen's CIK is 0001170542
Past Insider Trading and Trends
2008 was David M Tanen's most active year for acquiring shares with 7 total transactions. David M Tanen's most active month to acquire stocks was the month of November. 2020 was David M Tanen's most active year for disposing of shares, totalling 1 transactions. David M Tanen's most active month to dispose stocks was the month of September. 2008 saw David M Tanen paying a total of $14,137.00 for 88,000 shares, this is the most they've acquired in one year. In 2020 David M Tanen cashed out on 219,482 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +216.46% | 570.91K |
$16.15 |
—
| 834.66K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MANHATTAN PHARMACEUTICALS INC (TGTX) Snapshot price: $22.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.47% | 233.94K |
—
|
—
| 602.52K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
| No matching records found | |||||||||
Nile Therapeutics, Inc. (CAPR) Snapshot price: $4.09
Secretary and Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
| +0.16% | 2.5K |
$1.15 | $2,875.00 | 1.52M |
Dec 16
| |||
Form 4
| +0.43% | 6.5K |
$1.31 | $8,494.80 | 1.52M |
Dec 12 - Dec 15
| |||
Form 4
| +0.27% | 4K |
$0.69 | $2,767.20 | 1.51M |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arno Therapeutics, Inc No price found
Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +83.20% | 142.86K |
—
|
—
| 314.57K |
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
|
∞
| 362.01K |
$0.35 | $126,705.25 | 362.01K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cougar Biotechnology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||